Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 27 January, 2015

GlaxoSmithKline PLC

Board Committee Changes

RNS Number : 2739D
GlaxoSmithKline PLC
27 January 2015
 



GlaxoSmithKline plc (the "Company")

Board Committee changes

 

GSK announces that Sir Philip Hampton has been appointed Chairman of the Nominations Committee (the "Committee") with effect from today, replacing Sir Christopher Gent, who will continue to serve as a member of the Committee for the remainder of his tenure on the Board.

 

In addition,  Ms Lynn Elsenhans has also been appointed a member of the Committee, effective today.

 

The membership of the Nominations Committee is now:

 

Committee Chairman

 

Sir Philip Hampton

Chairman Designate

Members

Sir Christopher Gent

Chairman


Professor Sir Roy Anderson

Scientific & Medical Expert


Lynn Elsenhans

Independent Non Executive Director


Judy Lewent

Audit & Risk Committee Chairman


Sir Deryck Maughan

Senior Independent Director


Tom de Swaan

Remuneration Committee Chairman

 

V A Whyte

Company Secretary

 

27 January 2015


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPKODKQBKDODB

a d v e r t i s e m e n t